Global Micro-Invasive Glaucoma Surgery (MIGS) Devices Market, 2022: Market is Projected to Display a Robust Growth with a CAGR of 47.10%

Dublin, June 20, 2017 -- Research and Markets has announced the addition of the "Global Micro-Invasive Glaucoma Surgery (MIGS) Devices Market (By Target, By Surgery, By End User, By Region, By Country): Opportunities and Forecast (2017-2022) - By Target, By Surgery, By End User, By Region, By Country" report to their offering.

Global market is projected to display a robust growth represented by a CAGR of 47.10% during 2017 - 2022, chiefly driven by several MIGS devices entering the market in next five years, rising number of glaucoma patients and rapidly aging population, high safety profile and reduced dependency on prescription eye drops.

Over the recent years, the global Micro-Invasive Glaucoma Surgery industry has been growing rapidly as the global sales of iStent device by Glaukos which was the only commercially available device in United States has witnessed rapid growth post its FDA approval in 2012. Globally, the growth in micro-invasive glaucoma surgery device market is driven by several MIGS devices entering the market in next five years, rising number of glaucoma patients and rapidly aging population.

Among the targets, Trabecular Meshwork currently dominates the Micro-Invasive Glaucoma Surgery market. Among the surgeries, Stand Alone Glaucoma surgery is projected to witness fastest growth. In terms of End User, Ambulatory Surgery Centers is predicted to grow at a higher rate than HOPDs (Hospital Outpatient Departments). Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large glaucoma population and expansion of MIGS device in the region.

The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2013-2016, Forecast Period: 2017-2022)

Micro-Invasive Glaucoma Surgery Market

- Global MIGS Device Market, By Target (Trabecular Meshwork, Suprachoroidal Space, Others)
- Global MIGS Device Market, By Surgery (Glaucoma in Conjunction with Cataract, Stand Alone Glaucoma)
- Global MIGS Device Market, By End User (Hospital Outpatient Departments, Ambulatory Surgery Centers)

Regional Markets - N. America, Europe, APAC, ROW (Actual Period: 2012-2016, Forecast Period: 2017-2022)

Micro-Invasive Glaucoma Surgery Market

- Global MIGS Device Market, By Target
- Global MIGS Device Market, By Surgery
- Global MIGS Device Market, By End User

Country Analysis - US, Canada, UK, Germany, France, Japan, South Korea, Australia, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022)

Micro-Invasive Glaucoma Surgery Market

- Global MIGS Device Market, By Surgery in Percentage (2016, 2022)
- Global MIGS Device Market, By End User in Percentage (2016, 2022)

Other Report Highlights

- Market Dynamics - Trends, Drivers, Challenges
- Policy and Regulation
- Company Analysis - Glaukos, Alcon, Santen, Ivantis, Allergan

Customization of the Report

The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Product Overview

5. Global Micro-Invasive Glaucoma Surgery Device Market: Growth and Forecast

6. Global Micro-Invasive Glaucoma Surgery Devices Market - By Target

7. Global Micro-Invasive Glaucoma Surgery Devices Market - By Surgery

8. Global Micro-Invasive Glaucoma Surgery Market: Analysis By End User

9. Global Micro-Invasive Glaucoma Surgery Devices Market: Regional Analysis

10. Market Dynamics

11. Market Trends

12. Porter's Five Forces Analysis

13. SWOT Analysis

14. Policy and Regulatory Landscape

15. Company Profiles

• Alcon
• Allergan
• Glaukos
• Ivantis
• Santen Pharmaceuticals
  

For more information about this report visit https://www.researchandmarkets.com/research/z2pvkd/global

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Optical , Surgical Devices